Regorafenib and Durvalumab for the Treatment of High-Risk Liver Cancer

Clinical trial NCT05194293 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05194293
Sponsor: Academic and Community Cancer Research United
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Stage IB Hepatocellular Carcinoma AJCC v8 Stage II Hepatocellular Carcinoma AJCC v8 Stage III Hepatocellular Carcinoma AJCC v8 Stage IIIA Hepatocellular Carcinoma AJCC v8

Start date: 2023-07-01
Primary completion: 2025-12-05
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.